Humate-P: Difference between revisions
(Text replacement - "doesn't" to "does not") |
No edit summary |
||
| Line 1: | Line 1: | ||
== | ==Background== | ||
*Human Plasma-derived von Willebrand Factor | |||
*Contains both vWF and factor VIII | |||
==Indications== | ==Indications== | ||
*[[Hemophilia]] A (can also use factor VIII, [[FFP]] does not work well) | |||
*Von Willebrand disease that is unresponsive to DDAVP (can also use [[cryoprecipitate]], [[FFP]] does not work well) | |||
==Contraindications== | |||
*Allergy to class/drug | |||
==Administration== | |||
*Type: | |||
*Dosage Forms: | |||
*Routes of Administration: | |||
*Common Trade Names: | |||
==Adult Dosing== | |||
==Pediatric Dosing== | |||
==Special Populations== | |||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: | |||
*[[Lactation risk categories|Lactation risk]]: | |||
===Renal Dosing=== | |||
*Adult: | |||
*Pediatric: | |||
===Hepatic Dosing=== | |||
*Adult: | |||
*Pediatric: | |||
==Adverse Reactions== | |||
===Serious=== | |||
===Common=== | |||
==Pharmacology== | |||
*Half-life: | |||
*Metabolism: | |||
*Excretion: | |||
==Mechanism of Action== | |||
==Comments== | |||
==See Also== | ==See Also== | ||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Heme/Onc]] | [[Category:Heme/Onc]] | ||
Revision as of 00:28, 8 September 2016
Background
- Human Plasma-derived von Willebrand Factor
- Contains both vWF and factor VIII
Indications
- Hemophilia A (can also use factor VIII, FFP does not work well)
- Von Willebrand disease that is unresponsive to DDAVP (can also use cryoprecipitate, FFP does not work well)
Contraindications
- Allergy to class/drug
Administration
- Type:
- Dosage Forms:
- Routes of Administration:
- Common Trade Names:
Adult Dosing
Pediatric Dosing
Special Populations
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
